Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Recruiting now · Phase 3
Conditions studied: Endometrial Cancer
In brief
This study is designed to assess efficacy and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial cancer with various HER2 expression levels.
Key facts
- Study ID
- NCT07022483
- Run by
- Daiichi Sankyo
- People needed
- 710
- Starts
- 2025-09-30
- Expected to finish
- 2032-03-23
- Last updated by the study team
- 2026-07-28
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Miami Cancer Institute — Miami, Florida, United States (enrolling)
- Mount Sinai Medical Center — Miami Beach, Florida, United States (enrolling)
- Parkview Research Center — Fort Wayne, Indiana, United States (enrolling)
- Trials365 LLC — Shreveport, Louisiana, United States (enrolling)
- FirstHealth of the Carolinas, Inc. — Pinehurst, North Carolina, United States (enrolling)
- University of Cincinnati Physicians Group, LLC — Cincinnati, Ohio, United States (enrolling)
- Avera Medical Group Gynecologic Oncology Sioux Falls — Sioux Falls, South Dakota, United States (enrolling)
- Texas Oncology, P.A. - Tyler — Sioux Falls, South Dakota, United States (enrolling)
- Texas Oncology San Antonio Medical Center — San Antonio, Texas, United States (enrolling)
- Hospital Italiano de Buenos Aires — Ciudad Autonoma Buenos Aires, Argentina (enrolling)
- Sanatorio Allende Cerro — Córdoba, Argentina (enrolling)
- Centro de Investigaciones Medicas Mar del Plata — Mar del Plata, Argentina (enrolling)
- Instituto de Oncologia de Rosario — Rosario, Argentina (enrolling)
- CER San Juan Centro Polivalente de Asistencia e Inv. Clinica — San Juan, Argentina (enrolling)
- Biocenter — Concepción, Chile (enrolling)
- Centro de Estudios Clinicos SAGA — Santiago, Chile (enrolling)
- Centro de Investigaciones Clinicas de la Universidad Catolica — Santiago, Chile (enrolling)
- Beijing Cancer Hospital — Beijing, China (enrolling)
- The First Hospital of Jilin University — Changchun, China (enrolling)
- West China Second University Hospital, Sichuan University — Chengdu, China (enrolling)
- Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine — Hangzhou, China (enrolling)
- Zhejiang Cancer Hospital — Hangzhou, China (enrolling)
- Cancer Hospital of Shandong First Medical University — Jinan, China (enrolling)
- Linyi Cancer Hospital — Linyi, China (enrolling)
- Broward Health Medical Center — Fort Lauderdale, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.